These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 15851196)
1. Seasonal variation of mortality in the Antiarrhythmics Versus Implantable Defibrillators (AVID) study registry. Page RL; Zipes DP; Powell JL; Luceri RM; Gold MR; Peters R; Russo AM; Bigger JT; Sung RJ; McBurnie MA; Heart Rhythm; 2004 Oct; 1(4):435-40. PubMed ID: 15851196 [TBL] [Abstract][Full Text] [Related]
2. Follow-up of patients with unexplained syncope and inducible ventricular tachyarrhythmias: analysis of the AVID registry and an AVID substudy. Antiarrhythmics Versus Implantable Defibrillators. Steinberg JS; Beckman K; Greene HL; Marinchak R; Klein RC; Greer SG; Ehlert F; Foster P; Menchavez E; Raitt M; Wathen MS; Morris M; Hallstrom A J Cardiovasc Electrophysiol; 2001 Sep; 12(9):996-1001. PubMed ID: 11573709 [TBL] [Abstract][Full Text] [Related]
3. Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study. Steinberg JS; Martins J; Sadanandan S; Goldner B; Menchavez E; Domanski M; Russo A; Tullo N; Hallstrom A; Am Heart J; 2001 Sep; 142(3):520-9. PubMed ID: 11526368 [TBL] [Abstract][Full Text] [Related]
4. Distinct clinical features in the recipients of the implantable cardioverter defibrillator in Taiwan: a multicenter registry study. Tsai CT; Huang SK; Lin JL; Lai LP; Pacing Clin Electrophysiol; 2003 Nov; 26(11):2083-90. PubMed ID: 14622308 [TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study. Connolly SJ; Hallstrom AP; Cappato R; Schron EB; Kuck KH; Zipes DP; Greene HL; Boczor S; Domanski M; Follmann D; Gent M; Roberts RS Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258 [TBL] [Abstract][Full Text] [Related]
6. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294 [TBL] [Abstract][Full Text] [Related]
7. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS). Bokhari F; Newman D; Greene M; Korley V; Mangat I; Dorian P Circulation; 2004 Jul; 110(2):112-6. PubMed ID: 15238454 [TBL] [Abstract][Full Text] [Related]
8. The Italian Implantable Cardioverter-Defibrillator Registry. A survey of the national activity during the years 2001-2003. Proclemer A; Ghidina M; Cicuttini G; Gregori D; Fioretti PM Ital Heart J; 2005 Mar; 6(3):272-80. PubMed ID: 15875520 [TBL] [Abstract][Full Text] [Related]
9. In-hospital versus out-of-hospital presentation of life-threatening ventricular arrhythmias predicts survival: results from the AVID Registry. Antiarrhythmics Versus Implantable Defibrillators. Epstein AE; Powell J; Yao Q; Ocampo C; Lancaster S; Rosenberg Y; Cannom DS; Herre JM; Greene HL J Am Coll Cardiol; 1999 Oct; 34(4):1111-6. PubMed ID: 10520799 [TBL] [Abstract][Full Text] [Related]
10. Role of defibrillation threshold testing during implantable cardioverter-defibrillator placement: data from the Israeli ICD Registry. Arnson Y; Suleiman M; Glikson M; Sela R; Geist M; Amit G; Schliamser JE; Goldenberg I; Ben-Zvi S; Orvin K; Rosenheck S; Adam Freedberg N; Strasberg B; Haim M Heart Rhythm; 2014 May; 11(5):814-21. PubMed ID: 24486799 [TBL] [Abstract][Full Text] [Related]
11. Subanalyses of secondary prevention implantable cardioverter-defibrillator trials: antiarrhythmics versus implantable defibrillators (AVID), Canadian Implantable Defibrillator Study (CIDS), and Cardiac Arrest Study Hamburg (CASH). Oseroff O; Retyk E; Bochoeyer A Curr Opin Cardiol; 2004 Jan; 19(1):26-30. PubMed ID: 14688631 [TBL] [Abstract][Full Text] [Related]
12. Implantable cardioverter-defibrillators for treatment of sustained ventricular arrhythmias in patients with Chagas' heart disease: comparison with a control group treated with amiodarone alone. Gali WL; Sarabanda AV; Baggio JM; Ferreira LG; Gomes GG; Marin-Neto JA; Junqueira LF Europace; 2014 May; 16(5):674-80. PubMed ID: 24481778 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study. Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH; Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672 [TBL] [Abstract][Full Text] [Related]
14. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Ellenbogen KA; Levine JH; Berger RD; Daubert JP; Winters SL; Greenstein E; Shalaby A; Schaechter A; Subacius H; Kadish A; Circulation; 2006 Feb; 113(6):776-82. PubMed ID: 16461817 [TBL] [Abstract][Full Text] [Related]
15. Preventive effectiveness of implantable cardioverter defibrillator in reducing sudden cardiac death in the Chinese population: a multicenter trial of ICD therapy versus non-ICD therapy. Hua W; Niu H; Fan X; Ding L; Xu YZ; Wang J; Chen K; Wang F; Zhang S; J Cardiovasc Electrophysiol; 2012 Nov; 23 Suppl 1():S5-9. PubMed ID: 23140347 [TBL] [Abstract][Full Text] [Related]
16. Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications. Schinkel AF Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):562-8. PubMed ID: 23673907 [TBL] [Abstract][Full Text] [Related]
17. SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death. Au-Yeung WT; Reinhall PG; Poole JE; Anderson J; Johnson G; Fletcher RD; Moore HJ; Mark DB; Lee KL; Bardy GH Heart Rhythm; 2015 Oct; 12(10):2058-66. PubMed ID: 26096609 [TBL] [Abstract][Full Text] [Related]
18. [Idiopathic ventricular fibrillation: from a collection of clinical cases to a prospective evaluation. The U-CARE Steering Committee. Unexplained Cardiac Arrest Registry of Europe]. Priori SG; Paganini V; Boccalatte L; Schwartz PJ G Ital Cardiol; 1995 Feb; 25(2):149-58. PubMed ID: 7642019 [TBL] [Abstract][Full Text] [Related]
19. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study. Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108 [TBL] [Abstract][Full Text] [Related]
20. Prevalence, correlates, and temporal trends in antiarrhythmic drug use at discharge after implantable cardioverter defibrillator placement (from the National Cardiovascular Data Registry [NCDR]). Dev S; Peterson PN; Wang Y; Curtis JP; Varosy PD; Masoudi FA Am J Cardiol; 2014 Jan; 113(2):314-20. PubMed ID: 24216126 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]